← Research catalog Long-acting GHRH analog

CJC-1295

A modified GHRH analog studied alongside sermorelin in research settings.

What it is

CJC-1295 is a modified GHRH analog engineered for greater stability. Research literature distinguishes two forms: one with a DAC (drug affinity complex) modification for extended activity, and one without.

How it is studied

It is frequently characterized side by side with sermorelin in endocrine research models. Which form is used matters, because the two behave differently in the models that study them.

Purity and COA

Our COA states the form explicitly and confirms sequence and modification by mass spectrometry, with HPLC purity for the specific batch.

Handling

Store lyophilized powder cold and dry, reconstitute per your design, aliquot, and minimize freeze-thaw cycles.

Research use only. CJC-1295 is supplied for laboratory and research purposes only. It is not for human consumption and is not a drug, supplement, or medical device.